Filing Flows › Bodhi Tree Biotechnology (BDTB) › Q3 FY26 › vs Q2 FY26
Bodhi Tree Biotechnology (BDTB) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Bodhi Tree Biotechnology's revenue fell $5K (-33%) from $15K in Q2 FY26 to $10K in Q3 FY26.
Bodhi Tree Biotechnology, Q3 FY26: revenue $10K, operating margin -232.0%, net loss $23K, operating cash flow −$19K. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $10K | $15K | −$5K | -33% |
| Net loss | $23K | $29K | −$6K | -21% |
| Costs & expenses | $33K | $44K | −$11K | -25% |
| Operating costs | $33K | $43K | −$10K | -23% |
| Operating cash sources | $23K | $29K | −$6K | -21% |
| Working capital & other | $4K | $5K | −$150 | -3% |
| Cash used in operations | $19K | $25K | −$6K | -24% |
| Net loss absorbed | $23K | $29K | −$6K | -21% |
Questions
How much did Bodhi Tree Biotechnology's revenue grow quarter over quarter in Q3 FY26?
Bodhi Tree Biotechnology's revenue fell $5K (-33%) from $15K in Q2 FY26 to $10K in Q3 FY26.